…
Continue Reading about Harnessing Biologics for SLE Management: Pathways to Remission →
posted on
posted on
posted on
posted on
Chronic spontaneous urticaria (CSU) is a condition characterized by wheals, pruritus, and angioedema that occur spontaneously and recurrently over at least 6 weeks, incurring a significant impact on …
posted on
In this program, clinician-researchers explore these topics by offering their expert interpretation of clinical data and their relevance and clinical application. Additionally, they provide insight …
posted on
The 45-minute session will be designed to help dermatology providers increase their knowledge and understanding of Chronic Spontaneous Urticaria (CSU). Case examples will be utilized throughout the …
posted on
posted on
The pathophysiology of itch is complex and interacts with the type 2 inflammation that underlies common pruritic skin diseases, such as atopic dermatitis (AD), chronic spontaneous urticaria (CSU), and …
Continue Reading about Type 2 Inflammation in Common Pruritic Skin Diseases →
posted on
Urticaria is a condition characterized by the development of wheals (hives), angioedema, or both; it may be considered chronic if the symptoms persist for more than 6 weeks. In some patients, chronic …
Continue Reading about Chronic Spontaneous Urticaria: A Targeted Approach →
posted on
The availability of new and effective treatments for pruritic skin diseases has been a game changer for patients with atopic dermatitis, chronic spontaneous urticaria, and prurigo nodularis. In this …
Continue Reading about The Big Itch – Rapid Fire Cases: Ask The Experts →
posted on
The goal of this activity is for learners to be better able to explain the role of JAKs in the inflammatory response across autoimmune conditions and analyze the differences between the mechanisms of …
Continue Reading about The Science of Janus Kinase Inhibitors Across Immunologic Diseases →
posted on
The goal of this activity is for learners to be better able to contextualize current clinical evidence for JAK inhibitor therapies across key immunologic conditions. …
posted on
The goal of this activity is for learners to be better able to assess disease burden and emerging treatments for CSU, including their safety and efficacy data. …